Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL7302333

CCOC(=O)[C@H](Cc1ccc(OP(=O)(O)O)c(O)c1)NC(=O)[C@H](C)NC(=O)OCc1ccccc1.N

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 2/20 0.43
▸ ECE1 P42892 2/20 0.43
▸ CTSK P43235 1/20 0.43
▸ CTSL P07711 2/20 0.42
▸ F2 P00734 1/20 0.42
▸ CTSB P07858 1/20 0.42
▸ CTSS P25774 1/20 0.42
▸ TYR P14679 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ PRTN3 P24158 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL7425286 0.91 CAPN1 (0.51) MMEECE1CTSKCTSLCTSB
SCHEMBL9777172 0.90 CAPN1 (0.52) MMEECE1CTSKCTSLCTSB
Ammonia Solution, Strong SCHEMBL7300872 0.87 HSD17B10 (0.44) CTSKCTSLF2CTSBCTSS
SCHEMBL17693623 0.84 KYNU (0.53) CTSKCTSLF2CTSBCTSS
SCHEMBL7294519 0.82 GRB2 (0.46) —
SCHEMBL10952036 0.82 CTSL (0.57) CTSKCTSLCTSBCTSSHSD17B10
Ammonia Solution, Strong SCHEMBL9777157 0.80 HSD17B10 (0.44) CTSKCTSLF2CTSBCTSS
SCHEMBL7296829 0.78 GRB2 (0.47) —
SCHEMBL9777176 0.78 CAPN1 (0.54) CTSKCTSLCTSBCTSS
SCHEMBL7296176 0.78 TYR (0.55) CTSKCTSLCTSBCTSSTYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0393781-B1 Dopamine pro-drug ZAMBON SPA (IT) 1995-02-08 — — EP disclosed
US-5073547-A DOPAMINE PRO-DRUG SIMES SOCIETA ITALIANA MEDICINALI E SINTETICI S.P.A. (IT) 1991-12-17 — — US disclosed
EP-0393781-A2 Dopamine pro-drug ZAMBON GROUP S.p.A. (IT) 1990-10-24 — — EP disclosed
Send feedback